Diseases, Conditions, Syndromes

Fighting malaria through metabolism

EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite. The model offers unprecedented tools for developing a new generation of antimalarial therapies to overcome drug resistance.

Diseases, Conditions, Syndromes

First clinical evidence of drug-resistant malaria mutations gaining

New data provide the first clinical evidence that drug-resistant mutations in the malaria parasite Plasmodium falciparum may be gaining a foothold in Africa. The study, conducted in Rwanda, is published in The Lancet Infectious ...

Diseases, Conditions, Syndromes

A novel malaria vaccine vector that targets the liver

Malaria remains a deadly disease that affects people worldwide, particularly in Africa. Caused by a parasite that can enter the human bloodstream via mosquito bite, the parasites can then infect and reproduce within the person's ...

Diseases, Conditions, Syndromes

Cochrane Review on primaquine to prevent malaria transmission

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, conducted an independent review of the effects of adding a single dose of primaquine (PQ) to malaria treatment to prevent the transmission of the disease.

Diseases, Conditions, Syndromes

Fighting resistance to antimalarial drug

When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and ...

page 15 from 17